CN105213267A - A kind of preparation method of microcapsule-type anti-wrinkle eye cream - Google Patents

A kind of preparation method of microcapsule-type anti-wrinkle eye cream Download PDF

Info

Publication number
CN105213267A
CN105213267A CN201510721591.6A CN201510721591A CN105213267A CN 105213267 A CN105213267 A CN 105213267A CN 201510721591 A CN201510721591 A CN 201510721591A CN 105213267 A CN105213267 A CN 105213267A
Authority
CN
China
Prior art keywords
parts
microcapsule
eye cream
homogenizing
type anti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510721591.6A
Other languages
Chinese (zh)
Inventor
袁彦洁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHONGQING XIAOWAN TRADE Co Ltd
Original Assignee
CHONGQING XIAOWAN TRADE Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHONGQING XIAOWAN TRADE Co Ltd filed Critical CHONGQING XIAOWAN TRADE Co Ltd
Priority to CN201510721591.6A priority Critical patent/CN105213267A/en
Publication of CN105213267A publication Critical patent/CN105213267A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11Encapsulated compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • A61K8/355Quinones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/732Starch; Amylose; Amylopectin; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/733Alginic acid; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention discloses a kind of preparation method of microcapsule-type anti-wrinkle eye cream, with sodium alginate, Carboxymethyl cellulose sodium, hyaluronic acid, mink oil, squalane, lecithin, Jojoba wax, glycerol, serine, corn porous starch, Semen Granati ethanol extract, ganoderol extract, Flos Matricariae chamomillae ethanol extract, coenzyme Q10 and span 20 for raw material, prepare capsule wall solution A, capsule-core mixture B respectively, and after A and B is mixed, first dispersed with stirring carries out homogenizing again, finally homogenizing fluid C is instilled in calcium chloride solution, wash after filtration, obtained.The present invention adopts corn porous starch, lubricant component in core materials and active component are adsorbed, and then make microcapsule-type anti-wrinkle eye cream of the present invention in use, can make to be adsorbed on active component in corn porous starch and oils and fats slowly evenly discharges, and can not discharge in a large number the short time and bring too much nutrition and oil content to skin, and then can not cause the generation of fat granule, and the present invention also has the feature of good penetrability.

Description

A kind of preparation method of microcapsule-type anti-wrinkle eye cream
Technical field
The invention belongs to microcapsule technology field, be specifically related to a kind of preparation method of microcapsule-type anti-wrinkle eye cream.
Background technology
Eye skin is the thinnest skin of human body, is again activity position the most frequently simultaneously, but also is pull the maximum place of skin number of times in making up, and is very easy to grow wrinkle.The FAQs of eye has following several: black eye, eye pouch, edema, microgroove, dry stricture of vagina, crows-feet, fat granule, eyes lack expression etc., and these eye problems, once occur, are easy to make people seem aged without god.Eye cream is one of skin type product, and it can moisten eye part skin, alleviates the generation of wrinkle, microgroove, effectively prevents the generation of black eye, eye pouch problem, totally plays the effect alleviating eye part skin aging.Based on above-mentioned effect of eye cream, the personage that more and more likes to be beautiful using eye cream as one of daily indispensable skin care item.
If but the eye cream used is improper, also can bring certain harmful effect to eye skin.As most higher containing lubricant component in existing eye cream, contained neutraceutical active ingredients discharges too fast and is not easily absorbed, these oils and fatss or nutritional labeling are deposited on eye part skin, be easy to the generation causing fat granule for a long time in the past, fat granule, once produce elimination in the very difficult short time, can not be despised on the impact that eye part skin causes; If but the eye cream using quality comparatively frivolous, the moist degree of eye cream can be made again to decline, do not reach good maintenance effect.Moreover; the active substance adopted in existing eye cream is most not through certain protection, and directly contacts with external environment, along with the prolongation of time; these active substances be easy to be oxidized by the external world, photodissociation and lose the activity that should possess, and then cause product failure.
Summary of the invention
For prior art above shortcomings, technical problem to be solved by this invention is: the preparation method how providing a kind of microcapsule-type anti-wrinkle eye cream, the product Middle nutrition active component making the method obtained evenly can discharge in use and be easy to absorb, have nourish effective, can not cause that fat granule produces, active substance is not easily by feature that external environment is destroyed.
In order to solve the problems of the technologies described above, the present invention adopts following technical scheme: a kind of preparation method of microcapsule-type anti-wrinkle eye cream, comprises the steps:
1) material of following parts by weight is taken: 40 ~ 50 parts of sodium alginates, 10 ~ 15 parts of Carboxymethyl cellulose sodium, 6 ~ 8 parts of hyaluronic acids, 15 ~ 20 parts of mink oils, 8 ~ 12 parts of squalanes, 6 ~ 9 parts of lecithin, 4 ~ 10 parts of Jojoba waxes, 6 ~ 8 parts of glycerol, 3 ~ 6 parts of serines, 6 ~ 8 parts of corn porous starch, 2 ~ 3 parts of Semen Granati ethanol extract, 1 ~ 3 part of ganoderol extract, 2 ~ 3 parts of Flos Matricariae chamomillae ethanol extract, 1 ~ 2 part of coenzyme Q10 and 4 ~ 7 parts of span 20s;
2) add in deionized water by the sodium alginate taken, Carboxymethyl cellulose sodium and hyaluronic acid, at 70 ~ 80 DEG C, heating for dissolving 5 ~ 10min, obtains capsule wall solution A; Wherein, the deionized water volume added is 30 ~ 40 times of sodium alginate, Carboxymethyl cellulose sodium and hyaluronic acid gross mass;
3) mink oil, squalane, lecithin, Jojoba wax, glycerol, serine, corn porous starch, Semen Granati ethanol extract, ganoderol extract, Flos Matricariae chamomillae ethanol extract, coenzyme Q10 and the span 20 mix homogeneously that will take, under 70 ~ 80 DEG C of water bath condition, stir 0.5 ~ 1h, obtain capsule-core mixture B; The mixing speed of wherein said stirring is 120 ~ 160r/min;
4) mixed by capsule wall solution A and capsule-core mixture B, after blender dispersion 20 ~ 30min, homogenizing 5 ~ 10min, obtains homogenizing fluid C; Wherein, the rotating speed of described blender is 300 ~ 350r/min, and the homogenization pressure of described homogenizing is 35 ~ 50MPa;
5) homogenizing fluid C is heated to 70 ~ 80 DEG C, using glue head dropper that the homogenizing fluid C after heating is slowly added dropwise to mass concentration is in the calcium chloride solution of 5 ~ 7%;
6) calcium chloride solution after step 5) instillation homogenizing fluid C is filtered, discard filtrate, collect oversize;
7) to the oversize deionized water wash 2 ~ 3 times that step 6) is collected, the anti-wrinkle eye cream of described microcapsule-type is obtained.
Compared to existing technology, the present invention has following beneficial effect:
1, the present invention adopts corn porous starch to adsorb the lubricant component in core materials and active component, and then the microcapsule-type anti-wrinkle eye cream making the present invention prepare in use, can make to be adsorbed on active component in corn porous starch and oils and fats slowly evenly discharges, and can not discharge in a large number the short time and bring too much nutrition and oil content to skin, and then the generation of fat granule can not be caused.
2, in order to strengthen the permeability of microcapsule-type anti-wrinkle eye cream prepared by the present invention, the present invention is special by a large amount of experimental studies, choose mink oil, squalane, Jojoba wax is as core materials, and the collaborative compatibility relationship that further study between three, final discovery is when using " 15 ~ 20 parts of mink oils, 8 ~ 12 parts of squalanes and 4 ~ 10 parts of Jojoba waxes " time, the moist degree of this product can either be ensured, again can not be too greasy, and what is more important is when three plays collaborative compatibility effect with this ratio, the permeability of this product can be strengthened, and then enable skin fully absorb nutritional labeling, import respond well.
3, the present invention adopts microcapsule technology, neutraceutical active ingredients embedding is got up, makes this product in use, can not the impact that in external environment, light, heat, oxygen etc. are too much be subject to, effectively ensure that the activity of active substance is not destroyed, the effect extending product keeps the phase.
4, the present invention adopts active skull cap components as nutrient, and this several natural materials is carried out composite, make them farthest play collaborative compatibility effect, the preparation method of giving microcapsule-type anti-wrinkle eye cream of the present invention combines effect with crease-resistant, moisturizing, antioxidative.
5, cyst wall hydrogel material of the present invention brings certain water moisture feeling to this product, and hyaluronic interpolation further increases the performance of keeping humidity of product, make this product in use, it is easier that eye part skin is pushed open, only need massage gently with finger and get final product uniform application, use convenient, the overnutrition at this position will be made to cause fat granule because product is deposited in a certain position of eye part skin.
6, shape of product of the present invention is regular, cyst wall has uniform thickness, and has uniform intensity, can retain the perfect shape of microcapsule and not be destroyed, the problem that capsule-core is revealed can not be caused, can not be damaged during effectively ensureing product stock, transport, shelf life.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in further detail, in the present embodiment if no special instructions, raw materials used be commercially available.
Described Semen Granati ethanol extract, ganoderol extract, Flos Matricariae chamomillae ethanol extract are after the ethanol water of employing 75% carries out alcohol extraction to Semen Granati, Ganoderma and Flos Matricariae chamomillae respectively, successively the extract that obtains of decompression recycling ethanol, lyophilization.
Embodiment 1:
The present embodiment microcapsule-type anti-wrinkle eye cream is a kind of microcapsule of nucleocapsid structure, and cyst material is: 40 parts of sodium alginates, 10 parts of Carboxymethyl cellulose sodium and 6 parts of hyaluronic acids; Core materials is: 15 parts of mink oils, 8 parts of squalanes, 6 parts of lecithin, 4 parts of Jojoba waxes, 6 parts of glycerol, 3 parts of serines, 6 parts of corn porous starch, 2 parts of Semen Granati ethanol extract, 1 part of ganoderol extract, 2 parts of Flos Matricariae chamomillae ethanol extract, 1 part of coenzyme Q10 and 4 parts of span 20s.
Adopt and be prepared with the following method:
1) material of above-mentioned weight portion is taken;
2) add in deionized water by the sodium alginate taken, Carboxymethyl cellulose sodium and hyaluronic acid, heating for dissolving 5min at 70 DEG C, obtains capsule wall solution A; Wherein, the deionized water volume added is 30 times of sodium alginate, Carboxymethyl cellulose sodium and hyaluronic acid gross mass;
3) mink oil, squalane, lecithin, Jojoba wax, glycerol, serine, corn porous starch, Semen Granati ethanol extract, ganoderol extract, Flos Matricariae chamomillae ethanol extract, coenzyme Q10 and the span 20 mix homogeneously that will take, under 70 DEG C of water bath condition, stir 0.5h, obtain capsule-core mixture B; The mixing speed of wherein said stirring is 120r/min;
4) mixed by capsule wall solution A and capsule-core mixture B, after blender dispersion 20min, homogenizing 5min, obtains homogenizing fluid C; Wherein, the rotating speed of described blender is 300r/min, and the homogenization pressure of described homogenizing is 35MPa;
5) homogenizing fluid C is heated to 70 DEG C, using glue head dropper that the homogenizing fluid C after heating is slowly added dropwise to mass concentration is in the calcium chloride solution of 5%;
6) calcium chloride solution after step 5) instillation homogenizing fluid C is filtered, discard filtrate, collect oversize;
7) to the oversize deionized water wash 2 ~ 3 times that step 6) is collected, the anti-wrinkle eye cream of described microcapsule-type is obtained.
Embodiment 2:
A preparation method for microcapsule-type anti-wrinkle eye cream, be a kind of microcapsule of nucleocapsid structure, cyst material is: 50 parts of sodium alginates, 15 parts of Carboxymethyl cellulose sodium and 8 parts of hyaluronic acids; Core materials is: 20 parts of mink oils, 12 parts of squalanes, 9 parts of lecithin, 10 parts of Jojoba waxes, 8 parts of glycerol, 6 parts of serines, 8 parts of corn porous starch, 3 parts of Semen Granati ethanol extract, 3 parts of ganoderol extracts, 3 parts of Flos Matricariae chamomillae ethanol extract, 2 parts of coenzyme Q10s and 7 parts of span 20s.
Adopt and be prepared with the following method:
1) material of above-mentioned weight portion is taken;
2) add in deionized water by the sodium alginate taken, Carboxymethyl cellulose sodium and hyaluronic acid, heating for dissolving 10min at 80 DEG C, obtains capsule wall solution A; Wherein, the deionized water volume added is 40 times of sodium alginate, Carboxymethyl cellulose sodium and hyaluronic acid gross mass;
3) mink oil, squalane, lecithin, Jojoba wax, glycerol, serine, corn porous starch, Semen Granati ethanol extract, ganoderol extract, Flos Matricariae chamomillae ethanol extract, coenzyme Q10 and the span 20 mix homogeneously that will take, under 80 DEG C of water bath condition, stir 1h, obtain capsule-core mixture B; The mixing speed of wherein said stirring is 160r/min;
4) mixed by capsule wall solution A and capsule-core mixture B, after blender dispersion 30min, homogenizing 10min, obtains homogenizing fluid C; Wherein, the rotating speed of described blender is 350r/min, and the homogenization pressure of described homogenizing is 50MPa;
5) homogenizing fluid C is heated to 80 DEG C, using glue head dropper that the homogenizing fluid C after heating is slowly added dropwise to mass concentration is in the calcium chloride solution of 7%;
6) calcium chloride solution after step 5) instillation homogenizing fluid C is filtered, discard filtrate, collect oversize;
7) to the oversize deionized water wash 2 ~ 3 times that step 6) is collected, the anti-wrinkle eye cream of described microcapsule-type is obtained.
Embodiment 3:
A preparation method for microcapsule-type anti-wrinkle eye cream, be a kind of microcapsule of nucleocapsid structure, cyst material is: 42 parts of sodium alginates, 12 parts of Carboxymethyl cellulose sodium and 8 parts of hyaluronic acids; Core materials is: 18 parts of mink oils, 10 parts of squalanes, 8 parts of lecithin, 6 parts of Jojoba waxes, 8 parts of glycerol, 5 parts of serines, 6 parts of corn porous starch, 2 parts of Semen Granati ethanol extract, 1 part of ganoderol extract, 2 parts of Flos Matricariae chamomillae ethanol extract, 2 parts of coenzyme Q10s and 6 parts of span 20s.
Adopt and be prepared with the following method:
1) material of above-mentioned weight portion is taken;
2) add in deionized water by the sodium alginate taken, Carboxymethyl cellulose sodium and hyaluronic acid, heating for dissolving 10min at 75 DEG C, obtains capsule wall solution A; Wherein, the deionized water volume added is 35 times of sodium alginate, Carboxymethyl cellulose sodium and hyaluronic acid gross mass;
3) mink oil, squalane, lecithin, Jojoba wax, glycerol, serine, corn porous starch, Semen Granati ethanol extract, ganoderol extract, Flos Matricariae chamomillae ethanol extract, coenzyme Q10 and the span 20 mix homogeneously that will take, under 75 DEG C of water bath condition, stir 1h, obtain capsule-core mixture B; The mixing speed of wherein said stirring is 150r/min;
4) mixed by capsule wall solution A and capsule-core mixture B, after blender dispersion 25min, homogenizing 10min, obtains homogenizing fluid C; Wherein, the rotating speed of described blender is 330r/min, and the homogenization pressure of described homogenizing is 45MPa;
5) homogenizing fluid C is heated to 75 DEG C, using glue head dropper that the homogenizing fluid C after heating is slowly added dropwise to mass concentration is in the calcium chloride solution of 7%;
6) calcium chloride solution after step 5) instillation homogenizing fluid C is filtered, discard filtrate, collect oversize;
7) to the oversize deionized water wash 2 ~ 3 times that step 6) is collected, the anti-wrinkle eye cream of described microcapsule-type is obtained.
The present invention adopts corn porous starch, lubricant component in core materials and active component are adsorbed, and then the preparation method making microcapsule-type anti-wrinkle eye cream of the present invention in use, can make to be adsorbed on active component in corn porous starch and oils and fats slowly evenly discharges, and can not discharge in a large number the short time and bring too much nutrition and oil content to skin, and then the generation of fat granule can not be caused.
In order to strengthen the permeability of the microcapsule-type anti-wrinkle eye cream that the present invention obtains, the present invention is special by a large amount of experimental studies, choose mink oil, squalane, Jojoba wax is as core materials, and the collaborative compatibility relationship that further study between three, final discovery is when using " 15 ~ 20 parts of mink oils, 8 ~ 12 parts of squalanes and 4 ~ 10 parts of Jojoba waxes " time, the moist degree of this product can either be ensured, again can not be too greasy, and what is more important is when three plays collaborative compatibility effect with this ratio, the permeability of this product can be strengthened, and then enable skin fully absorb nutritional labeling, import respond well.
What finally illustrate is, above embodiment is only in order to illustrate technical scheme of the present invention and unrestricted, although applicant's reference preferred embodiment is to invention has been detailed description, those of ordinary skill in the art is to be understood that, technical scheme of the present invention is modified or equivalent replacement, and do not depart from the aim of technical solution of the present invention and scope, all should be encompassed in the middle of right of the present invention.

Claims (5)

1. a preparation method for microcapsule-type anti-wrinkle eye cream, is characterized in that, comprises the steps:
1) material of following parts by weight is taken: 40 ~ 50 parts of sodium alginates, 10 ~ 15 parts of Carboxymethyl cellulose sodium, 6 ~ 8 parts of hyaluronic acids, 15 ~ 20 parts of mink oils, 8 ~ 12 parts of squalanes, 6 ~ 9 parts of lecithin, 4 ~ 10 parts of Jojoba waxes, 6 ~ 8 parts of glycerol, 3 ~ 6 parts of serines, 6 ~ 8 parts of corn porous starch, 2 ~ 3 parts of Semen Granati ethanol extract, 1 ~ 3 part of ganoderol extract, 2 ~ 3 parts of Flos Matricariae chamomillae ethanol extract, 1 ~ 2 part of coenzyme Q10 and 4 ~ 7 parts of span 20s;
2) add in deionized water by the sodium alginate taken, Carboxymethyl cellulose sodium and hyaluronic acid, at 70 ~ 80 DEG C, heating for dissolving 5 ~ 10min, obtains capsule wall solution A; Wherein, the deionized water volume added is 30 ~ 40 times of sodium alginate, Carboxymethyl cellulose sodium and hyaluronic acid gross mass;
3) mink oil, squalane, lecithin, Jojoba wax, glycerol, serine, corn porous starch, Semen Granati ethanol extract, ganoderol extract, Flos Matricariae chamomillae ethanol extract, coenzyme Q10 and the span 20 mix homogeneously that will take, under 70 ~ 80 DEG C of water bath condition, stir 0.5 ~ 1h, obtain capsule-core mixture B; The mixing speed of wherein said stirring is 120 ~ 160r/min;
4) mixed by capsule wall solution A and capsule-core mixture B, after blender dispersion 20 ~ 30min, homogenizing 5 ~ 10min, obtains homogenizing fluid C; Wherein, the rotating speed of described blender is 300 ~ 350r/min, and the homogenization pressure of described homogenizing is 35 ~ 50MPa;
5) homogenizing fluid C is heated to 70 ~ 80 DEG C, using glue head dropper that the homogenizing fluid C after heating is slowly added dropwise to mass concentration is in the calcium chloride solution of 5 ~ 7%;
6) calcium chloride solution after step 5) instillation homogenizing fluid C is filtered, discard filtrate, collect oversize;
7) to the oversize deionized water wash 2 ~ 3 times that step 6) is collected, the anti-wrinkle eye cream of described microcapsule-type is obtained.
2. the preparation method of microcapsule-type anti-wrinkle eye cream according to claim 1, is characterized in that, step 2) at 75 DEG C, heat 10min.
3. the preparation method of microcapsule-type anti-wrinkle eye cream according to claim 1, it is characterized in that, the mixing speed stirred described in step 3) is 150r/min.
4. the preparation method of microcapsule-type anti-wrinkle eye cream according to claim 1, is characterized in that, with after blender dispersion 25min in step 4), and homogenizing 10min.
5. the preparation method of microcapsule-type anti-wrinkle eye cream according to claim 1, it is characterized in that, the rotating speed of blender described in step 4) is 330r/min, and the homogenization pressure of described homogenizing is 45MPa.
CN201510721591.6A 2015-10-30 2015-10-30 A kind of preparation method of microcapsule-type anti-wrinkle eye cream Pending CN105213267A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510721591.6A CN105213267A (en) 2015-10-30 2015-10-30 A kind of preparation method of microcapsule-type anti-wrinkle eye cream

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510721591.6A CN105213267A (en) 2015-10-30 2015-10-30 A kind of preparation method of microcapsule-type anti-wrinkle eye cream

Publications (1)

Publication Number Publication Date
CN105213267A true CN105213267A (en) 2016-01-06

Family

ID=54982793

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510721591.6A Pending CN105213267A (en) 2015-10-30 2015-10-30 A kind of preparation method of microcapsule-type anti-wrinkle eye cream

Country Status (1)

Country Link
CN (1) CN105213267A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115252439A (en) * 2022-08-03 2022-11-01 中国药科大学 Smearing type skin care product composition containing millimeter capsules and preparation method thereof
WO2023135170A1 (en) * 2022-01-13 2023-07-20 Givaudan Sa Composition

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391288B1 (en) * 1999-07-27 2002-05-21 Shiseido Co., Ltd. Microcapsule and method of making the same
CN103202469A (en) * 2013-03-28 2013-07-17 吉林大学 Egg yolk lecithin microcapsules and preparation method thereof
CN104398392A (en) * 2014-12-01 2015-03-11 重庆小丸科贸有限公司 Hydrogel microcapsule and application thereof in anti-ageing cosmetic

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391288B1 (en) * 1999-07-27 2002-05-21 Shiseido Co., Ltd. Microcapsule and method of making the same
CN103202469A (en) * 2013-03-28 2013-07-17 吉林大学 Egg yolk lecithin microcapsules and preparation method thereof
CN104398392A (en) * 2014-12-01 2015-03-11 重庆小丸科贸有限公司 Hydrogel microcapsule and application thereof in anti-ageing cosmetic

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
吴克刚等: "《食品微胶囊技术》", 31 July 2006 *
杨晓东等: "《日用化学品生产技术》", 31 July 2008 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023135170A1 (en) * 2022-01-13 2023-07-20 Givaudan Sa Composition
CN115252439A (en) * 2022-08-03 2022-11-01 中国药科大学 Smearing type skin care product composition containing millimeter capsules and preparation method thereof
CN115252439B (en) * 2022-08-03 2023-12-19 中国药科大学 Smearing type skin care product composition containing millimeter capsules and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103948035B (en) A kind of preparation method of peony seed oil microcapsule
CN103734474B (en) Beautifying health-care tea and preparation method thereof
CN104042502B (en) A kind of percdation absorbs and the skin care compositions of the slow down aging that enhances metabolism
CN103816101B (en) A kind of manufacture method of facial mask powder
CN107496325A (en) Facial mask containing peony essential oil, green cucumber extract solution and snail stoste and preparation method thereof
CN103705414A (en) Eye cream customized for Night Cats
CN104306262A (en) Beauty mask
CN104644528B (en) A kind of preparation method and application of edible moisture-keeping nutrient ointment
CN104523476A (en) Eye cream for improving eye bags, dark eye circles and removing wrinkles, preparation method and application thereof
CN105213283A (en) A kind of bright eye cream of microcapsule-type
CN105310894A (en) Microcapsule type anti-wrinkle eye cream
CN105769601A (en) Walnut enzyme whitening and nourishing mud mask and preparation method thereof
CN105213203A (en) A kind of preparation method of microcapsule-type moisturizing eye cream
CN104473841A (en) Traditional Chinese medicine mask containing dendrobe
CN105168057A (en) Figwort root body wash
CN102423289B (en) Beautifying membrane capable of complete absorption
CN105213267A (en) A kind of preparation method of microcapsule-type anti-wrinkle eye cream
CN103462855B (en) Cosmetic containing American ginseng and longan and preparation method thereof
CN105902452A (en) Preparation method of natural anti-aging facial mask liquid
CN105395450A (en) Premna microphylla lactic acid face application agent
CN101744758A (en) Honey facial mask with moisturizing factor
CN103919710A (en) Facial mask capable of improving sleeping and preparation method thereof
CN105748329A (en) Separated chitin horse oil mask
CN104004616A (en) Sweet wine yeast composition having health-care effect, and preparation method thereof
CN107137316B (en) Dendrobium lip balm and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160106

RJ01 Rejection of invention patent application after publication